Company page

Theriva Biologics, Inc.

Theriva Biologics, Inc. is a public company traded under the ticker TOVX in the American market. With a market capitalization of approximately $13.94 million, the company focuses on developing innovative biologic therapies. Theriva aims to address unmet medical needs through its specialized research and development efforts.